Table 1 Vaccine strategies evaluated in the study
| Â | Â | Base policy | ||||||
|---|---|---|---|---|---|---|---|---|
| Â | Â | No vaccination | Risk group only (Pre-2000 ) | Risk group and elderly (Post-2000) | Risk group (75 %) and elderly | |||
Extension | None | X | X | X | X | |||
2–4 years | 50 % | 50 % | 15 % | 30 % | 50 % | 70 % | 50 % | |
50–64 years | 50 % | 50 % | 15 % | 30 % | 50 % | 70 % | 50 % | |
5–16 years | 50 % | 50 % | 15 % | 30 % | 50 % | 70 % | 50 % | |
2–4 and 50–64 years | 50 % | 50 % | 15 % | 30 % | 50 % | 70 % | 50 % | |
2–16 years | 50 % | 50 % | 15 % | 30 % | 50 % | 70 % | 50 % | |
2–16 and 50–64 years | 50 % | 50 % | 15 % | 30 % | 50 % | 70 % | 50 % | |
2–64 years | 50 % | 50 % | 15 % | 30 % | 50 % | 70 % | 50 % | |